| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |